HHC is a psychoactive cannabinoid with a similar, according to scene
reports, slightly lower effect than THC. More
information on the substance may be found on
There are currently no study data on the toxicity, neurotoxicity, or carcinogenicity of HHC. Therefore, we do not
know whether HHC damages organs or nerves or can cause cancer.
HHC may be found in trace amounts in cannabis plants. However, the HHC contained in products for sale is always
(As of summer 2022)
Numerous by-products are created during the production of HHC. All HHC products sent to our laboratory so far did
contain unknown by-products or THC from the production process (as of summer 2022). The following applies
in particular to these unknown by-products: We do not know whether they can damage organs or nerves or cause cancer.
The possession and consumption of HHC products are not prohibited in Europe as of Summer 2022.
We assume that trade of HHC products for the purpose of consumption (swallowing, vaping, smoking) is most likely
prohibited in Europe. The expected penalties are unclear and depend on which and how many laws have been violated.
Among these laws are: Food Safety and Consumer Protection Act (LMSVG), New Psychotropic Substances Act (NPSG),
Medicines Act (AMG) and, in the case of tobacco products, the Tobacco and Non-Smokers Protection Act (TNRSG).
If someone is harmed by the consumption of an HHC product, the producer and/or seller may be held responsible as the
competent person under
Section 88 of the Criminal Code
(negligent physical injury).
We at the IFHA see our role as supporting companies in improving the
quality, product and consumer safety of hemp and hemp products. We, therefore, recommend not to trade or to consume